The active management of intrahepatic cholestasis of pregnancy

Purpose of review To review the literature regarding the active management of intrahepatic cholestasis of pregnancy. Recent findings There has been an increasing trend toward the active management of cholestasis of pregnancy. This trend exists because clinicians have yet to discover adequate solutions to avert the morbidities and mortalities associated with the disorder. It is believed that early intervention by induction of labor before the 38th week of gestation will decrease the incidence of intrauterine fetal demise associated with cholestasis of pregnancy. It is also believed that treating the clinical symptoms of cholestasis with 2–5 ursodeoxycholic acid will improve maternal symptoms, facilitate the prolongation of pregnancy, and possibly improve fetal outcomes. Summary The current literature encourages the induction of labor between 37–38 weeks' gestation in order to reduce the incidence of stillbirth in women with intrahepatic cholestasis of pregnancy. The most widely used medication for both the treatment of maternal pruritus and the elevations in maternal liver enzymes associated with cholestasis of pregnancy is 2–5 ursodeoxycholic acid. Neither mode of practice has been subjected to randomized clinical trials.

[1]  Martin Wagner,et al.  New molecular insights into the mechanisms of cholestasis. , 2009, Journal of hepatology.

[2]  C. Andres,et al.  ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy , 2009, Journal of Medical Genetics.

[3]  M. Downes,et al.  Hepatobiliary ABC transporters: physiology, regulation and implications for disease. , 2009, Frontiers in bioscience.

[4]  J. Thornton,et al.  Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis , 2009, BMC pregnancy and childbirth.

[5]  V. Geenes,et al.  Intrahepatic cholestasis of pregnancy , 2014, Obstetrics and gynecology.

[6]  O. Oztekin,et al.  Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy , 2009, Archives of Gynecology and Obstetrics.

[7]  David A. Miller,et al.  Sudden Fetal Death in Intrahepatic Cholestasis of Pregnancy , 2009, Obstetrics and gynecology.

[8]  S. Lucangioli,et al.  Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment , 2009, Annals of clinical biochemistry.

[9]  L. Kupčinskas,et al.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. , 2008, World journal of gastroenterology.

[10]  C. Romagnoli,et al.  Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. , 2008, Early human development.

[11]  S. Ingles,et al.  Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. , 2008, American journal of perinatology.

[12]  C. Romagnoli,et al.  Bile Acid-Induced Lung Injury in Newborn Infants: A Bronchoalveolar Lavage Fluid Study , 2008, Pediatrics.

[13]  S. Sookoian,et al.  Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. , 2008, Journal of hepatology.

[14]  M. Saleh,et al.  Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. , 2007, Journal of women's health.

[15]  T. Pusl,et al.  Intrahepatic cholestasis of pregnancy , 2007, Orphanet journal of rare diseases.

[16]  C. Overton,et al.  Consensus on the management of obstetric cholestasis. National UK survey , 2007, BJOG : an international journal of obstetrics and gynaecology.

[17]  F. Lammert,et al.  Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene , 2006, Gut.

[18]  M. Saleh,et al.  Short communication: Consensus on the management of obstetric cholestasis: National UK survey , 2006, BJOG : an international journal of obstetrics and gynaecology.

[19]  T. Goodwin,et al.  The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population , 2006, Journal of Perinatology.

[20]  L. Marpeau,et al.  Fetal Death in a Patient With Intrahepatic Cholestasis of Pregnancy , 2006, Obstetrics and gynecology.

[21]  J. Ribalta,et al.  Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[22]  L. Mattsson,et al.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates , 2004, Hepatology.

[23]  C. Romagnoli,et al.  Bile acid pneumonia: a "new" form of neonatal respiratory distress syndrome? , 2004, Pediatrics.

[24]  Y. Korchev,et al.  Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. , 2002, Clinical science.

[25]  A. Shennan,et al.  Obstetric cholestasis, outcome with active management: a series of 70 cases , 2002, BJOG : an international journal of obstetrics and gynaecology.

[26]  A. Mannermaa,et al.  Maternal susceptibility locus for obstetric cholestasis maps to chromosome region 2p13 in Finnish patients. , 2001, Scandinavian journal of gastroenterology.

[27]  W. Sepulveda,et al.  Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. , 1991, European journal of obstetrics, gynecology, and reproductive biology.